Cancer Treatment
Findings from the United Kingdom, Switzerland and France in cancer treatment provide new insights
Published in Vaccine Weekly, August 9th, 2006
Study 1: Scientists have identified a major histocompatibility complex class I-restricted T-cell epitope in the tumor-associated antigen, 5T4.
According to their report, "5T4 is a surface glycoprotein expressed on placental trophoblasts and also on a wide range of human carcinomas. Its highly restricted expression on normal tissues and broad distribution on many carcinomas make 5T4 a promising target for cancer immunotherapy."
"In the current study, we set out to investigate whether a 5T4-specific cytotoxic T lymphocyte (CTL)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-08-09)
More Articles from Vaccine Weekly
- Breast Cancer Vaccine
CIITA-induced MHC class II expression leads to breast tumor rejection - Cancer Vaccine
Dendritic cell vaccine induces T cell response against tongue squamous carcinoma - Contraception
Sperm DNA vaccine has contraceptive effects in female mice - Pancreatic Cancer
Connective tissue growth factor-specific monoclonal antibodies inhibit pancreatic tumors - Vaccine Efficacy
IL-2 signals during priming are required for expansion of CD8+ memory T cells - Adrenocortical Cancer
Adrenocortical carcinoma management depends on better understanding of molecular pathogenesis - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
